Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time

Wednesday, July 17, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. has announced it will host a conference call and webcast on July 31, 2024, at 8:00 a.m. ET to discuss its second quarter financial and operational results for the year. The company encourages participants to register online in advance. A replay of the event will be made available for at least 30 days after the live broadcast. Lantheus is recognized for its long-standing commitment to delivering innovative radiopharmaceutical solutions.
Price reaction · baseline $118.3 (2024-07-16 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close · peak
+2.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is providing a platform to share its financial achievements through the conference call.
  • The company has a strong track record of over 65 years in radiopharmaceutical solutions.
  • The event indicates transparency and engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second quarter of 2024.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is Lantheus Holdings' next conference call?

The next conference call is scheduled for July 31, 2024, at 8:00 a.m. ET.

How can I access the Lantheus conference call?

Participants can register online at Lantheus' investor website to access the call.

Will a replay of the conference call be available?

Yes, a replay will be available two hours after the webcast and archived for 30 days.

What does Lantheus Holdings specialize in?

Lantheus Holdings specializes in radiopharmaceuticals, enhancing disease management.

Where is Lantheus Holdings headquartered?

Lantheus Holdings is headquartered in Bedford, Massachusetts.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Lantheus radiopharmaceuticals financial results conference call
Last updated: Jul 17, 2024

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →